TMCnet News

HeartSine Wins Two Prestigious Management Awards for its Success in Expanding Global Business
[May 12, 2014]

HeartSine Wins Two Prestigious Management Awards for its Success in Expanding Global Business


BELFAST, Northern Ireland & NEWTOWN, Pa. --(Business Wire)--

HeartSine Technologies, a world leader in personal and public access defibrillators, has won two prestigious BVCA (British Private Equity & Venture Capital Association) Management Team Awards for the Northern Ireland region: Private Equity-backed Management Team of the Year (Mid Market) Award and International Impact Management Team of the Year Award.

Open to management teams of mid-market private equity-backed companies, the Private Equity-backed Management Team of the Year (Mid Market) award recognizes a management team's outstanding contribution to the growth of the company, demonstrating strategic vision and overall development of the business.

The International Impact Management Team of the Year award acknowledges the leadership and achievement of portfolio company management teams in unlocking value and contributing to the development and success of their businesses on an international scale.

With a presence on every major continent, HeartSine is experiencing rapid growth across the globe, especially in emerging markets. This growth has led to an expansion of the company's Belfast facility, which is home to HeartSine's R&D, quality and manufacturing teams.

"Its a great honor for our highly experienced, hard-working management team to be recognized by such a prestigious organization--especially for our international success," says Declan O'Mahoney, CEO of HeartSine Technologies. "Our global expansion is a direct result of the team's commitment to excellence, innovation and quality."



The only awards in the world dedicated to the management teams of UK businesses backed by private equity and venture capital, the BVCA Management Team Awards have been designed to celebrate managerial excellence, and underline what an important role private equity and venture capital plays in the national economy. For more details about the awards, visit www.bvca-mta.com.

About HeartSine Technologies:


HeartSine Technologies, a world leader in personal and public access defibrillators, advances the deployment of life-saving defibrillation therapy for the treatment of Sudden Cardiac Arrest in non-traditional areas of care.

Designed for use in public areas, the company's entire line of Automatic External Defibrillator (AED) products leverages its proprietary, clinically advanced SCOPE technology to optimize the administration of life-saving treatment.

The company's flagship product line, the HeartSine samaritan® PAD (Public Access Defibrillator), is IP56 rated for durability and exceptional reliability to meet the unique environmental demands of public use. Its industry-leading warranty and innovative battery/electrode Pad-Pak combine to give the samaritan PAD the lowest total cost of ownership. HeartSine AEDS are deployed in over 70 countries worldwide in a wide range of environments, including commercial aircraft, military and shipping facilities, manufacturing plants, offices, schools and sports clubs.

HeartSine is based Newtown, Pennsylvania and Belfast, Northern Ireland. To learn how a HeartSine AED can save lives, please visit www.heartsine.com.


[ Back To TMCnet.com's Homepage ]